Press release
Von Willebrand Disease Treatment Market And Key Players Octapharma, Shire Plc, BDI Pharma, Baxalta, Ferring Pharmaceuticals, CSL Behring, and Grifols Therapeutics
Von Willebrand Disease Treatment
"Rapid FDA approvals is expected to fuel the growth of von Willebrand Disease (vWD) treatment market"
Rapid approvals of vWD treatment therapies and drugs from FDA and marketing approvals in different region are expected to fuel growth of von Willebrand Disease (vWD) treatment market in near future. In 2015, the U.S. Food and Drug Administration (FDA) was granted approval for Octapharma’s WILATE a replacement therapy for patients suffering from von Willebrand Disease (vWD).
In 2017, European Medicines Agency (EMA) granted authorization for the marketing of VEYVONDI to prevent and treat von Willebrand Disease. VEYVONDI is a replacement therapy developed by Shire plc, which was FDA approved in 2015. Rapid marketing permission of drugs is expected to fuel Von Willebrand Disease (vWD) Treatment Market in near future. The major factor restraining the growth of von Willebrand Disease (vWD) treatment market is lack of awareness about disease and its diagnosis as it is a very rare disease.
Get PDF for more Professional and Technical insights@
https://www.coherentmarketinsights.com/insight/request-sample/1154
Von Willebrand Disease (vWD) Treatment Market Taxonomy
The von Willebrand Disease (vWD) treatment market is segmented on the basis of disease type and treatment type.
On the basis of disease type, the von Willebrand Disease (vWD) treatment market is segment into:
Type 1 vWD
Type 2 vWD
Type 3 vWD
Acquired vWD
On the basis of treatment type, the von Willebrand Disease (vWD) treatment market is segment into:
Desmopressin
Replacement therapies
Contraceptives
Clot-stabilizing medications
Drugs applied to cuts
Key players are organizing various symposiums to raise awareness about von Willebrand Disease and to increase brand visibility.
Key players in von Willebrand Disease (vWD) treatment market include Octapharma, Shire Plc, BDI Pharma, Baxalta, Ferring Pharmaceuticals, CSL Behring, and Grifols Therapeutics Inc. In 2017, Octapharma organized a symposium at the International Society on Thrombosis and Haemostasis (ISTH) congress in Berlin to support progress in lifelong treatment for patients with von Willebrand Disease (vWD) and to spread knowledge about their latest replacement therapy WILATE for treatment of von Willebrand Disease.
Von Willebrand Disease (vWD) is a common bleeding disorder caused due to missing or defect in von Willebrand factor (VWF), a clotting factor which helps blood to clot. Low amount of Willebrand factor (VWF) leads to severe and bleeding. There are four types of vWD namely Type 1 vWD, Type 2 vWD, Type 3 vWD, and Acquired vWD. Desmopressin is a common drug used for treatment of vWD, which is an antidiuretic hormone that triggers the release of VWF into the plasma and may increase levels of factor VIII.
Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1154
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Von Willebrand Disease Treatment Market And Key Players Octapharma, Shire Plc, BDI Pharma, Baxalta, Ferring Pharmaceuticals, CSL Behring, and Grifols Therapeutics here
News-ID: 1315626 • Views: …
More Releases from Coherent Market Insights - Pharmaceutical Industry
Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data.
Ask For Sample Copy of Research…
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development.
Ask For a Sample Copy of This Business Report @…
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players.
Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976
Market…
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around…
More Releases for Willebrand
Von Willebrand Disease Treatment Market To Reach Valuation Of ~US$ 900 Mn By 203 …
Von Willebrand Disease Treatment Market: Introduction
According to the report, the global von Willebrand disease treatment market was valued at US$ 471.1 Mn in 2019 and is projected to expand at a CAGR of ~6% from 2020 to 2030. Von Willebrand disease is an inherited bleeding disorder caused due to deficiency or dysfunction of von Willebrand factor (VWF). Moreover, genetic mutation is one of the causes of von Willebrand disease. Defects…
Growing Healthcare Expenditure Lead To Extensive Sales In Von Willebrand Disease …
The Fact.MR report offers insight into the Competitive Dynamic in Von Willebrand Disease Treatment Market which has shaped the major strategies of each player. It also covers recent moves such as partnerships and collaborations, mergers and acquisitions, diversification and research investments, of each prominent player.
The key factors that shape the entry barrier and intensity of competition in the Von Willebrand Disease Treatment market are presented in the analysis. Further, the…
Von Willebrand disease treatment therapies and Von Willebrand Disease treatment …
The research report presents a comprehensive assessment of the Von Willebrand Disease Treatment Market and contains thoughtful insights, facts, historical data and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application and industry
To remain ‘ahead’ of your competitors, request for a sample - https://www.factmr.com/connectus/sample?flag=S&rep_id=1496
Von Willebrand Disease…
Global Von Willebrand Disease (VWD) Therapeutics Market Growth Data Analysis 202 …
The global Von Willebrand Disease (VWD) Therapeutics market 2020 mainly focuses on the market trend, market share, size and forecast. It is a brief and professional analysis on the current scenario of the Global Von Willebrand Disease (VWD) Therapeutics market.
The report on Von Willebrand Disease (VWD) Therapeutics market is a comprehensive study on global market analysis and insights. The report focuses on the emerging trends in the global and regional spaces on all the significant…
Von Willebrand Disease Treatment Market to Witness Steady Growth through 2018-20 …
Von Willebrand disease is a bleeding defect that delays the process of blood clotting. It is seen in both, females and males, irrespective of the race. It is a genetic disorder which is carried on chromosome number 12. According to the World Federation of Hemophilia, Von Willebrand disease is a very common bleeding defect. People suffering from the Von Willebrand disease have a defect in the protein present in their…
Von Willebrand Disease Treatment Market Revenue, Opportunity, Forecast and Value …
Von Willebrand disease is a bleeding defect that delays the process of blood clotting. It is seen in both, females and males, irrespective of the race. It is a genetic disorder which is carried on chromosome number 12. According to the World Federation of Hemophilia, Von Willebrand disease is a very common bleeding defect. People suffering from the Von Willebrand disease have a defect in the protein present in their…
